Hypomethylation of repeated DNA sequences in cancer

Epigenomics

Volumn 2, Issue 2, 2010, Pages 245-269

  Ross, Jason P ^a   Rand, Keith N ^a   Molloy, Peter L ^a  

^a CSIRO   (Australia)

Author keywords

cancer; DNA hypomethylation; epigenome; repeat sequences; retrotransposons

Indexed keywords

DNA METHYLTRANSFERASE; TRANSFER RNA;

AGING; ALU SEQUENCE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CHROMOSOMAL INSTABILITY; DNA METHYLATION; DNA SEQUENCE; GENE CONTROL; GENE DOSAGE; HUMAN; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; REGULATORY RNA SEQUENCE; REVIEW; TELOMERE;

CHROMOSOMAL INSTABILITY; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 77954137460     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.2     Document Type: Review

References (250)

1. Rollins RA, Haghighi F, Edwards JR et al.: Large-scale structure of genomic methylation patterns. Genome Res. 16(2), 157-163 (2006).
2. Ehrlich M: Cancer-linked DNA hypomethylation and its relationship to hypermethylation. In: DNA Methylation: Development, Genetic Disease and Cancer. Doerfer W, Böhm P (Eds). Springer, Berlin, Germany, 251-274 (2006).
3. Feinberg A P, Ohlsson R, Henikoff S: The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7(1), 21-33 (2006).
4. Ting AH, McGarvey KM, Baylin SB: The cancer epigenome-components and functional correlates. Genes Dev. 20(23), 3215-3231 (2006).
5. Hoffmann MJ, Schulz WA: Causes and consequences of DNA hypomethylation in human cancer. Biochem. Cell Biol. 83(3), 296-321 (2005).
6. Wilson AS, Power BE, Molloy PL: DNA hypomethylation and human diseases. Biochim. Biophys. Acta 1775(1), 138-162 (2007).
7. Pogribny IP, Beland FA: DNA hypomethylation in the origin and pathogenesis of human diseases. Cell. Mol. Life Sci. 66(14), 2249-2261 (2009).
8. Recent review of hypomethylation of DNA as it relates to human pathology with a particular emphasis on one carbon metabolism, nutrition and environmental factors.Ehrlich M: DNA hypomethylation in cancer cells. Epigenomics 1(2), 239-259 (2009).
9. Ammerpohl O, Martin-Subero JI, Richter J, Vater I, Siebert R: Hunting for the 5th base: techniques for analyzing DNA methylation. Biochim. Biophys. Acta 1790(9), 847-862 (2009).
10. Chang JW, Huang THM, Wang YC: Emerging methods for ana lysis of the cancer methylome. Pharmacogenomics 9(12), 1869-1878 (2008).
11. Cohen CJ, Lock WM, Mager DL: Endogenous retroviral LTRs as promoters for human genes: a critical assessment. Gene 448(2), 105-114 (2009).
12. Lander ES, Linton LM, Birren B et al.: Initial sequencing and ana lysis of the human genome. Nature 409(6822), 860-921 (2001).
13. Cedar H, Bergman Y: Linking DNA methylation and histone modifcation: patterns and paradigms. Nat. Rev. Genet. 10(5), 295-304 (2009).
14. Gangemi R, Paleari L, Orengo AM et al.: Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr. Med. Chem. 16(14), 1688-1703 (2009).
15. Jirtle RL: Epigenome: the program for human health and disease. Epigenomics 1(1), 13-16 (2009).
16. Pradhan S, Esteve PO: Mammalian DNA (cytosine-5) methyltransferases and their expression. Clin. Immunol. 109(1), 6-16 (2003).
17. Hermann A, Gowher H, Jeltsch A: Biochemistry and biology of mammalian DNA methyltransferases. Cell. Mol. Life Sci. 61(19-20), 2571-2587 (2004).
18. Goll MG, Bestor TH: Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74, 481-514 (2005).
19. Klose RJ, Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31(2), 89-97 (2006).
20. Schaefer CB, Ooi SKT, Bestor TH, Bourc'his D: Epigenetic decisions in mammalian germ cells. Science 316(5823), 398-399 (2007).
21. Kato Y, Kaneda M, Hata K et al.: Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse. Hum. Mol. Genet. 16(19), 2272-2280 (2007).
22. Chedin F, Lieber MR, Hsieh CL: The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc. Natl Acad. Sci. USA 99(26), 16916-16921 (2002).
23. Chen ZX, Mann JR, Hsieh CL, Riggs AD, Chedin F: Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J. Cell. Biochem. 95(5), 902-917 (2005).
24. Zhu H, Geiman TM, Xi S et al.: Lsh is involved in de novo methylation of DNA. EMBO J. 25(2), 335-345 (2006).
25. De la Fuente R, Baumann C, Fan T, Schmidtmann A, Dobrinski I, Muegge K: Lsh is required for meiotic chromosome synapsis and retrotransposon silencing in female germ cells. Nat. Cell Biol. 8(12), U1448-U1485 (2006).
26. Maksakova IA, Mager DL, Reiss D: Keeping active endogenous retroviral-like elements in check: the epigenetic perspective. Cell. Mol. Life Sci. 65(21), 3329-3347 (2008).
27. Kurihara Y, Kawamura Y, Uchijima Y et al.: Maintenance of genomic methylation patterns during preimplantation development requires the somatic form of DNA methyltransferase 1. Dev. Biol. 313(1), 335-346 (2008).
28. Mertineit C, Yoder JA, Taketo T, Laird DW, Trasler JM, Bestor TH: Sex-specifc exons control DNA methyltransferase in mammalian germ cells. Development 125(5), 889-897 (1998).
29. Okano M, Bell DW, Haber DA, Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3), 247-257 (1999).
30. Yamagata K, Yamazaki T, Miki H et al.: Centromeric DNA hypomethylation as an epigenetic signature discriminates between germ and somatic cell lineages. Dev. Biol. 312(1), 419-426 (2007).
31. Lane N, Dean W, Erhardt S et al.: Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse. Genesis 35(2), 88-93 (2003).
32. Muegge K: Lsh, a guardian of heterochromatin at repeat elements. Biochem. Cell Biol. 83(4), 548-554 (2005).
33. Suzuki T, Farrar JE, Yegnasubramanian S, Zahed M, Suzuki N, Arceci RJ: Stable knockdown of PASG enhances DNA demethylation but does not accelerate cellular senescence in TIG-7 human fbroblasts. Epigenetics 3(5), 281-291 (2008).
34. Yehezkel S, Segev Y, Viegas-Pequignot E, Skorecki K, Selig S: Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum. Mol. Genet. 17(18), 2776-2789 (2008).
35. Lister R, Pelizzola M, Dowen RH et al.: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271), 315-322 (2009).
36. Suetake I, Miyazaki J, Murakami C, Takeshima H, Tajima S: Distinct enzymatic properties of recombinant mouse DNA methyltransferases Dnmt3a and Dnmt3b. J. Biochem. 133(6), 737-744 (2003).
37. Oakes CC, La Salle S, Smiraglia DJ, Robaire B, Trasler JM: A unique confguration of genome-wide DNA methylation patterns in the testis. Proc. Natl Acad. Sci. USA 104(1), 228-233 (2007).
38. Bourc'his D, Bestor TH: Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 431(7004), 96-99 (2004).
39. Hata K, Kusumi M, Yokomine T, Li E, Sasaki H: Meiotic and epigenetic aberrations in Dnmt3L-defcient male germ cells. Mol. Reprod. Dev. 73(1), 116-122 (2006).
40. Kondo T, Bobek MP, Kuick R et al.: Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum. Mol. Genet. 9(4), 597-604 (2000).
41. Brock GJR, Charlton J, Bird A: Densely methylated sequences that are preferentially localized at telomere-proximal regions of human chromosomes. Gene 240(2), 269-277 (1999).
42. Gonzalo S, Jaco I, Fraga MF et al.: DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol. 8(4), 416-424 (2006).
43. Steinert S, Shay J W, Wright WE: Modifcation of subtelomeric DNA. Mol. Cell. Biol. 24(10), 4571-4580 (2004).
44. Benetti R, Garcia-Cao M, Blasco MA: Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet. 39(2), 243-250 (2007).
45. El-Maarri O, Kareta MS, Mikeska T et al.: A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation. Hum. Mol. Genet. 18(10), 1755-1768 (2009).
46. Lewis A, Reik W: How imprinting centres work. Cytogenet. Genome Res. 113(1-4), 81-89 (2006).
47. Royo H, Bortolin ML, Seitz H, Cavaille J: Small non-coding RNAs and genomic imprinting. Cytogenet. Genome Res. 113(1-4), 99-108 (2006).
48. Migeon BR: X chromosome inactivation: theme and variations. Cytogenet. Genome Res. 99(1-4), 8-16 (2002).
49. Bernstein E, Allis CD: RNA meets chromatin. Genes Dev. 19(14), 1635-1655 (2005).
50. Martienssen RA, Zaratiegui M, Goto DB: RNA interference and heterochromatin in the fssion yeast Schizosaccharomyces pombe. Trends Genet. 21(8), 450-456 (2005).
51. Grewal SI, Elgin SC: Transcription and RNA interference in the formation of heterochromatin. Nature 447(7143), 399-406 (2007).
52. Aravin AA, Hannon GJ, Brennecke J: The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race. Science 318(5851), 761-764 (2007).
53. Eymery A, Callanan M, Vourc'h C: The secret message of heterochromatin: new insights into the mechanisms and function of centromeric and pericentric repeat sequence transcription. Int. J. Dev. Biol. 53(2-3), 259-268 (2009).
54. Frescas D, Guardavaccaro D, Kuchay SM et al.: KDM2A represses transcription of centromeric satellite repeats and maintains the heterochromatic state. Cell Cycle 7(22), 3539-3547 (2008).
55. Wong LH, Brettingham-Moore KH, Chan L et al.: Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere. Genome Res. 17(8), 1146-1160 (2007).
56. Watanabe T, Totoki Y, Toyoda A et al.: Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature 453(7194), 539-543 (2008).
57. Girard A, Sachidanandam R, Hannon GJ, Carmell MA: A germline-specifc class of small RNAs binds mammalian Piwi proteins. Nature 442(7099), 199-202 (2006).
58. Aravin AA, Sachidanandam R, Bourc'his D et al.: A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice. Mol. Cell 31(6), 785-799 (2008).
59. Aravin AA, Sachidanandam R, Girard A, Fejes-Toth K, Hannon GJ: Developmentally regulated piRNA clusters implicate MILI in transposon control. Science 316(5825), 744-747 (2007).
60. Carmell MA, Girard A, van de Kant HJG et al.: MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev. Cell 12(4), 503-514 (2007).
61. Kuramochi-Miyagawa S, Watanabe T, Gotoh K et al.: DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. Genes Dev. 22(7), 908-917 (2008).
62. Aravin AA, Bourc'his D: Small RNA guides for de novo DNA methylation in mammalian germ cells. Genes Dev. 22(8), 970-975 (2008).
63. Issa JP: CpG-island methylation in aging and cancer. Curr. Top. Microbiol. Immunol. 249, 101-118 (2000).
64. Fuke C, Shimabukuro M, Petronis A et al.: Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann. Hum. Genet. 68(Pt 3), 196-204 (2004).
65. Bollati V, Schwartz J, Wright R et al.: Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech. Ageing Dev. 130(4), 234-239 (2009).
66. Chalitchagorn K, Shuangshoti S, Hourpai N et al.: Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23(54), 8841-8846 (2004).
67. Suzuki K, Suzuki I, Leodolter A et al.: Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9(3), 199-207 (2006).
68. Maeda T, Guan JZ, Oyama J, Higuchi Y, Makino N: Age-related changes in subtelomeric methylation in the normal Japanese population. J. Gerontol. A Biol. Sci. Med. Sci. 64(4), 426-434 (2009).
69. Maeda T, Guan JZ, Higuchi Y, Oyama J, Makino N: Aging-related alterations of subtelomeric methylation in sarcoidosis patients. J. Gerontol. A Biol. Sci. Med. Sci. 64(7), 752-760 (2009).
70. Choi SH, Worswick S, Byun HM et al.: Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer. Int. J. Cancer 125(3), 723-729 (2009).
71. Szpakowski S, Sun XG, Lage JM et al.: Loss of epigenetic silencing in tumors preferentially affects primate-specifc retroelements. Gene 448(2), 151-167 (2009).
72. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3(6), 415-428 (2002).
73. Jones PA, Baylin SB: The epigenomics of cancer. Cell 128(4), 683-692 (2007).
74. Banerjee HN, Verma M: Epigenetic mechanisms in cancer. Biomark. Med. 3(4), 397-410 (2009).
75. Weisenberger DJ, Campan M, Long TI et al.: Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 33(21), 6823-6836 (2005).
76. Ehrlich M, Woods CB, Yu MC et al.: Quantitative ana lysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene 18, 2636-2645 (2006).
77. Cadieux B, Ching TT, VandenBerg SR, Costello JF: Genome-wide hypomethylation in human glioblastomas associated with specifc copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res. 66(17), 8469-8476 (2006).
78. Park SY, Yoo EJ, Cho NY et al.: Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratifed for Helicobacter pylori infection. J. Pathol. 219(4), 410-416 (2009).
79. Bollati V, Fabris S, Pegoraro V et al.: Differential repetitive DNA methylation in multiple myeloma molecular subgroups. Carcinogenesis 30(8), 1330-1335 (2009).
80. Daskalos A, Nikolaidis G, Xinarianos G et al.: Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int. J. Cancer 124(1), 81-87 (2009).
81. Rauch TA, Zhong XY, Wu XW et al.: High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc. Natl Acad. Sci. USA 105(1), 252-257 (2008).
82. Costa FF, Paixao VA, Cavalher FP et al.: SATR-1 hypomethylation is a common and early event in breast cancer. Cancer Genet. Cytogenet. 165(2), 135-143 (2006).
83. Suter CM, Martin DI, Ward RL: Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int. J. Colorectal Dis. 19(2), 95-101 (2004).
84. Moore LE, Pfeiffer RM, Poscablo C et al.: Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol. 9(4), 359-366 (2008).
85. Choi J-Y, James SR, Link PA et al.: Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 30(11), 1889-1897 (2009).
86. Pufulete M, Al-Ghnaniem R, Leather AJ et al.: Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case-control study. Gastroenterology 124(5), 1240-1248 (2003).
87. Lim U, Flood A, Choi SW et al.: Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology 134(1), 47-55 (2008).
88. Hsiung DT, Marsit CJ, Houseman EA et al.: Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomark. Prev. 16(1), 108-114 (2007).
89. Fenech M: The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 20(4), 255-269 (2005).
90. Widschwendter M, Jiang G, Woods C et al.: DNA hypomethylation and ovarian cancer biology. Cancer Res. 64(13), 4472-4480 (2004).
91. Ogino S, Nosho K, Kirkner GJ et al.: A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J. Natl. Cancer Inst. 100(23), 1734-1738 (2008).
92. Sharma S, Kelly TK, Jones PA: Epigenetics in cancer. Carcinogenesis 31(1), 27-36 (2009).
93. Yoo CB, Jones PA: Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug Discov. 5(1), 37-50 (2006).
94. Issa PJ: DNA methylation as a therapeutic target in cancer. Clin. Cancer Res. 13(6), 1634-1637 (2007).
95. Issa PJ, Byrd JC: Decitabine in chronic leukemias. Semin. Hematol. 42, S43-S49 (2005).
96. Yoo CB, Chuang JC, Byun HM et al.: Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. Cancer Prev. Res. (Phila. PA). 1(4), 233-240 (2008).
97. Crea F, Giovannetti E, Cortesi F et al.: Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines. Mol. Cancer Ther. 8(7), 1964-1973 (2009).
98. Liu ZF, Liu SJ, Xie ZL et al.: Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specifc and sensitive LC-MS/MS method. Nucleic Acids Res. 35(5), E31 (2007).
99. Yang AS, Doshi KD, Choi SW et al.: DNA methylation changes after 5-aza-2́-deoxycytidine therapy in patients with leukemia. Cancer Res. 66(10), 5495-5503 (2006).
100. Kaneda A, Tsukamoto T, Takamura-Enya T et al.: Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci. 95(1), 58-64 (2004).
101. Grunau C, Sanchez C, Ehrlich M et al.: Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer. Genes Chromosomes Cancer 43(1), 11-24 (2005).
102. Neuhausen A, Florl AR, Grimm MO, Schulz WA: DNA methylation alterations in urothelial carcinoma. Cancer Biol. Ther. 5(8), 982-990 (2006).
103. Furuta J, Umebayashi Y, Miyamoto K et al.: Promoter methylation profling of 30 genes in human malignant melanoma. Cancer Sci. 95(12), 962-968 (2004).
104. Bariol C, Suter C, Cheong K et al.: The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am. J. Pathol. 162(4), 1361-1371 (2003). (Pubitemid 36350680)
105. Frigola J, Sole X, Paz MF et al.: Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum. Mol. Genet. 14(2), 319-326 (2005).
106. Rodriguez J, Frigola J, Vendrell E et al.: Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res. 66(17), 8462-9468 (2006).
107. Ehrlich M, Jiang G, Fiala E et al.: Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 21(43), 6694-6702 (2002).
108. Pini JT, Franchina M, Taylor JM, Kay PH: Evidence that general genomic hypomethylation and focal hypermethylation are two independent molecular events of non-Hodgkin's lymphoma. Oncol. Res. 14(7-8), 399-405 (2004).
109. Ogino S, Kawasaki T, Nosho K et al.: LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int. J. Cancer 122(12), 2767-2773 (2008). (Pubitemid 351631379)
110. Matsuzaki K, Deng G, Tanaka H, Kakar S, Miura S, Kim YS: The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin. Cancer Res. 11(24), 8564-8569 (2005).
111. Estecio MR, Gharibyan V, Shen L et al.: LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS ONE 2(5), E399 (2007).
112. Iacopetta B, Grieu F, Phillips M et al.: Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci. 98(9), 1454-1460 (2007).
113. Nosho K, Shima K, Irahara N et al.: DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin. Cancer Res. 15(11), 3663-3671 (2009).
114. Fan T, Schmidtmann A, Xi S et al.: DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development. Epigenetics 3(3), 134-142 (2008).
115. Trinh BN, Long TI, Nickel AE, Shibata D, Laird PW: DNA methyltransferase defciency modifes cancer susceptibility in mice lacking DNA mismatch repair. Mol. Cell. Biol. 22(9), 2906-2917 (2002).
116. Gaudet F, Hodgson JG, Eden A et al.: Induction of tumors in mice by genomic hypomethylation. Science 300(5618), 489-492 (2003).
117. Eden A, Gaudet F, Waghmare A, Jaenisch R: Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300(5618), 455 (2003).
118. Yamada Y, Jackson-Grusby L, Linhart H et al.: Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl Acad. Sci. USA 102(38), 13580-13585 (2005).
119. Karpf AR, Matsui S: Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res. 65(19), 8635-8639 (2005).
120. Wong N, Lam WC, Lai PBS, Pang E, Lau WY, Johnson PJ: Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am. J. Pathol. 159(2), 465-471 (2001).
121. Ehrlich M: The ICF syndrome, a DNA methyltransferase 3B defciency and immunodefciency disease. Clin. Immunol. 109(1), 17-28 (2003).
122. Nakagawa T, Kanai Y, Ushijima S, Kitamura T, Kakizoe T, Hirohashi S: DNA hypomethylation on pericentromeric satellite regions signifcantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas. J. Urol. 173(1), 243-246 (2005).
123. Tsuda H, Takarabe T, Kanai Y, Fukutomi T, Hirohashi S: Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas. Am. J. Pathol. 161(3), 859-866 (2002).
124. Davidsson J, Andersson A, Paulsson K et al.: Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3. Hum. Mol. Genet. 16(18), 2215-2225 (2007).
125. Kim NW, Piatyszek MA, Prowse KR et al.: Specifc association of human telomerase activity with immortal cells and cancer. Science 266(5193), 2011-2015 (1994).
126. Vera E, Canela A, Fraga MF, Esteller M, Blasco MA: Epigenetic regulation of telomeres in human cancer. Oncogene 27(54), 6817-6833 (2008).
127. Lee ME, Rha SY, Jeung HC, Chung HC, Oh BK: Subtelomeric DNA methylation and telomere length in human cancer cells. Cancer Lett. 281(1), 82-91 (2009).
128. Tilman G, Loriot A, Van Beneden A et al.: Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene 28(14), 1682-1693 (2009).
129. Deng GR, Nguyen A, Tanaka H et al.: Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer. Int. J. Cancer 118(12), 2999-3005 (2006).
130. Schulz WA, Elo JP, Florl AR et al.: Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 35(1), 58-65 (2002).
131. Schulz WA, Alexa A, Jung V et al.: Factor interaction ana lysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer. Mol. Cancer 6, 14 (2007).
132. Kolomietz E, Meyn MS, Pandita A, Squire JA: The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35(2), 97-112 (2002).
133. Florl AR, Schulz WA: Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells. Genes Chromosomes Cancer 37(2), 141-148 (2003).
134. Hsieh SY, Chen WY, Yeh TS, Sheen IS, Huang SF: High-frequency Alu-mediated genomic recombination/deletion within the caspase-activated DNase gene in human hepatoma. Oncogene 24(43), 6584-6589 (2005).
135. Schulz WA, Steinhoff C, Florl AR: Methylation of endogenous human retroelements in health and disease. Curr. Top. Microbiol. Immunol. 310, 211-250 (2006).
136. Kim M, Trinh BN, Long TI, Oghamian S, Laird PW: Dnmt1 defciency leads to enhanced microsatellite instability in mouse embryonic stem cells. Nucleic Acids Res. 32(19), 5742-5749 (2004).
137. Guo G, Wang W, Bradley A: Mismatch repair genes identifed using genetic screens in Blm-defcient embryonic stem cells. Nature 429(6994), 891-895 (2004).
138. Howard G, Eiges R, Gaudet F, Jaenisch R, Eden A: Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 27(3), 404-408 (2008).
139. Liu J, Nau MM, Zucman-Rossi J, Powell JI, Allegra CJ, Wright JJ: LINE-I element insertion at the t(11;22) translocation breakpoint of a desmoplastic small round cell tumor. Genes Chromosomes Cancer 18(3), 232-239 (1997).
140. Han JS, Boeke JD: A highly active synthetic mammalian retrotransposon. Nature 429(6989), 314-318 (2004).
141. Brouha B, Schustak J, Badge RM et al.: Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl Acad. Sci. USA 100(9), 5280-5285 (2003).
142. Faulkner GJ, Kimura Y, Daub CO et al.: The regulated retrotransposon transcriptome of mammalian cells. Nat. Genet. 41(5), 563-571 (2009).
143. Conley AB, Miller WJ, Jordan IK: Human cis natural antisense transcripts initiated by transposable elements. Trends Genet. 24(2), 53-56 (2008).
144. Matlik K, Redik K, Speek M: L1 antisense promoter drives tissue-specifc transcription of human genes. J. Biomed. Biotech. 2006(1), 71753 (2006).
145. Faulkner GJ, Carninci P: Altruistic functions for selfsh DNA. Cell Cycle 8(18), 2895-2900 (2009).
146. Osato N, Suzuki Y, Ikeo K, Gojobori T: Transcriptional interferences in cis natural antisense transcripts of humans and mice. Genetics 176(2), 1299-1306 (2007).
147. Cruickshanks HA, Tufarelli C: Isolation of cancer-specifc chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter. Genomics 94(6), 397-406 (2009).
148. Lin L, Wang Z W, Prescott MS et al.: Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinoma. Genes Chromosomes Cancer 45(4), 319-331 (2006).
149. Roman-Gomez J, Jimenez-Velasco A, Agirre X et al.: Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 24(48), 7213-7223 (2005).
150. Davis CD, Uthus EO: DNA methylation, cancer susceptibility, and nutrient interactions. Exp. Biol. Med. (Maywood) 229(10), 988-995 (2004).
151. Giovannucci E: Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J. Nutr. 134(9), S2475-S2481 (2004).
152. Pogribny IP, Ross SA, Wise C et al.: Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl defciency. Mutat. Res. 593(1-2), 80-87 (2006).
153. Lewis SJ, Harbord RM, Harris R, Smith GD: Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J. Natl. Cancer Inst. 98(22), 1607-1622 (2006).
154. Bollati V, Baccarelli A, Hou L et al.: Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67(3), 876-880 (2007).
155. Purohit V, Khalsa J, Serrano J: Mechanisms of alcohol-associated cancers: introduction and summary of the symposium. Alcohol 35(3), 155-160 (2005).
156. Smith IM, Mydlarz WK, Mithani SK, Califano JA: DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int. J. Cancer 121(8), 1724-1728 (2007).
157. Figueiredo JC, Grau MV, Wallace K et al.: Global DNA hypomethyation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol. Biomark. Prev. 18(4), 1041-1049 (2009).
158. Minarovits J: Microbe-induced epigenetic alterations in host cells: the coming era of patho-epigenetics of microbial infections; a review. Acta Microbiol. Immunol. Hung. 56(1), 1-19 (2009).
159. Park IY, Sohn BH, Yu E et al.: Aberrant epigenetic modifcations in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132(4), 1476-1494 (2007).
160. De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X, Nelson WG: Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59(16), 3855-3860 (1999).
161. Li S, Chiang TC, Richard-Davis G, Barrett JC, McLachlan JA: DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma. Gynecol. Oncol. 90(1), 123-130 (2003).
162. Etoh T, Kanai Y, Ushijima S et al.: Increased DNA methyltransferase 1 (DNMT1) protein expression correlates signifcantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am. J. Pathol. 164(2), 689-699 (2004).
163. Agoston AT, Argani P, Yegnasubramanian S et al.: Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J. Biol. Chem. 280(18), 18302-18310 (2005).
164. Peng DF, Kanai Y, Sawada M et al.: Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci. 96(7), 403-408 (2005).
165. Loriot A, De Plaen E, Boon T, De Smet C: Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells. J. Biol. Chem. 281(15), 10118-10126 (2006).
166. Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S: DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int. J. Cancer 91(2), 205-212 (2001).
167. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S: Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 33(3), 561-568 (2001).
168. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S: Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3B4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc. Natl Acad. Sci. USA 99(15), 10060-10065 (2002).
169. Almstrup K, Hoei-Hansen CE, Nielsen JE et al.: Genome-wide gene expression profling of testicular carcinoma in situ progression into overt tumours. Br. J. Cancer 92(10), 1934-1941 (2005).
170. Ostler K, Davis E, Payne S et al.: Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins. Oncogene 26(38), 5553-5563 (2007).
171. Morgan HD, Santos F, Green K, Dean W, Reik W: Epigenetic reprogramming in mammals. Hum. Mol. Genet. 14(Spec. 1), R47-R58 (2005).
172. Lucarelli M, Fuso A, Strom R, Scarpa S: The dynamics of myogenin site-specifc demethylation is strongly correlated with its expression and with muscle differentiation. J. Biol. Chem. 276(10), 7500-7506 (2001).
173. Bruniquel D, Schwartz RH: Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 4(3), 235-240 (2003).
174. Ma DK, Jang MH, Guo JU et al.: Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 323(5917), 1074-1077 (2009).
175. Brown SE, Szyf M: Epigenetic programming of the rRNA promoter by MBD3. Mol. Cell. Biol. 27(13), 4938-4952 (2007).
176. Schmitz KM, Schmitt N, Hoffmann-Rohrer U, Schafer A, Grummt I, Mayer C: TAF12 recruits Gadd45a and the nucleotide excision repair complex to the promoter of rRNA genes leading to active DNA demethylation. Mol. Cell 33(3), 344-353 (2009).
177. Niehrs C: Active DNA demethylation and DNA repair. Differentiation 77(1), 1-11 (2009).
178. Jin SG, Guo C, Pfeifer GP: GADD45A does not promote DNA demethylation. PLoS Genet. 4(3), E1000013 (2008).
179. Fraga MF, Ballestar E, Villar-Garea A et al.: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37(4), 391-400 (2005).
180. Gallais R, Demay F, Barath P et al.: Deoxyribonucleic acid methyl transferases 3a and 3b associate with the nuclear orphan receptor COUP-TFI during gene activation. Mol. Endocrinol. 21(9), 2085-2098 (2007).
181. Detich N, Bovenzi V, Szyf M: Valproate induces replication-independent active DNA demethylation. J. Biol. Chem. 278(30), 27586-27592 (2003).
182. Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK: Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues-implications for epigenetic reprogramming. J. Biol. Chem. 279(50), 52353-52360 (2004).
183. Kouzarides T: Chromatin modifcations and their function. Cell 128(4), 693-705 (2007).
184. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G: Genome regulation by Polycomb and trithorax proteins. Cell 128(4), 735-745 (2007).
185. Santos-Rosa H, Caldas C: Chromatin modifer enzymes, the histone code and cancer. Eur. J. Cancer 41(16), 2381-2402 (2005).
186. Esteller M: Cancer epigenomics: DNA methylomes and histone-modifcation maps. Nat. Rev. Genet. 8(4), 286-298 (2007).
187. Filippova GN: Genetics and epigenetics of the multifunctional protein CTCF. Curr. Top. Dev. Biol. 80, 337-360 (2008).
188. Chadwick BP: DXZ4 chromatin adopts an opposing conformation to that of
189. Ottaviani A, Rival-Gervier S, Boussouar A et al.: The D4Z4 macrosatellite repeat Acts as a CTCF and A-type lamins-dependent insulator in facio-scapulo-humeral dystrophy. PLoS Genet. 5(2), E1000394 (2009).
190. Lee DW, Zhang K, Ning Z-Q et al.: Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia. Cancer Res. 60(13), 3612-3622 (2000).
191. Yano M, Ouchida M, Shigematsu H et al.: Tumor-specifc exon creation of the HELLS/SMARCA6 gene in non-small cell lung cancer. Int. J. Cancer 112(1), 8-13 (2004).
192. Lehnertz B, Ueda Y, Derijck AA et al.: Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13(14), 1192-1200 (2003).
193. Pauler FM, Sloane MA, Huang R et al.: H3K27me3 forms BLOCs over silent genes and intergenic regions and specifes a histone banding pattern on a mouse autosomal chromosome. Genome Res. 19(2), 221-233 (2009).
194. Martens JHA, O'Sullivan RJ, Braunschweig U et al.: The profle of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 24(4), 800-812 (2005).
195. Ellinger J, Kahl P, von der Gathen J et al.: Global levels of histone modifcations predict prostate cancer recurrence. Prostate 70(1), 61-69 (2010).
196. Seligson DB, Horvath S, McBrian MA et al.: Global levels of histone modifcations predict prognosis in different cancers. Am. J. Pathol. 174(5), 1619-1628 (2009).
197. Fraga MF, Ballestar E, Villar-Garea A et al.: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37(4):391-400 (2005).
198. Wiemer EAC: The role of microRNAs in cancer: no small matter. Eur. J. Cancer 43(10), 1529-1544 (2007).
199. Ryazansky SS, Gvozdev VA: Small RNAs and cancerogenesis. Biochemistry (Mosc.) 73(5), 514-527 (2008).
200. Calin GA, Sevignani C, Dumitru CD et al.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA 101(9), 2999-3004 (2004).
201. Smalheiser NR, Torvik VI: Mammalian microRNAs derived from genomic repeats. Trends Genet. 21(6), 322-326 (2005).
202. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, James RJ: Reduced accumulation of specifc microRNAs in colorectal neoplasia. Mol. Cancer Res. 1(12), 882-891 (2003).
203. Ng EKO, Tsang WP, Ng SSM et al.: MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer 101(4), 699-706 (2009).
204. Fabbri M, Garzon R, Cimmino A et al.: MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA 104(40), 15805-15810 (2007).
205. +) stem cells express the HIWI gene, a human homologue of the Drosophila gene piwi. Blood 97(2), 426-434 (2001).
206. Taubert H, Greither T, Kaushal D et al.: Expression of the stem cell self-renewal gene HIWI and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene 26(7), 1098-1100 (2007).
207. Grochola LF, Greither T, Taubert H et al.: The stem cell-associated HIWI gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death. Br. J. Cancer 99(7), 1083-1088 (2008).
208. Qiao D, Zeeman AM, Deng W, Looijenga LH, Lin HF: Molecular characterization of HIWI, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 21(25), 3988-3999 (2002).
209. Lee JH, Schutte D, Wulf G et al.: Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-X-L pathway. Hum. Mol. Genet. 15(2), 201-211 (2006).
210. Gao JX: Cancer stem cells: the lessons from pre-cancerous stem cells. J. Cell. Mol. Med. 12(1), 67-96 (2008).
211. Thanasupawat T, Phokaew C, Mutirangura A: The association between Piwil2 expression and LINE-1 methylation in cancer cells. Asian Biomed. 3(3), 279-285 (2009).
212. Jeffery L, Nakielny S: Components of the DNA methylation system of chromatin control are RNA-binding proteins. J. Biol. Chem. 279(47), 49479-49487 (2004).
213. Kapranov P, Cheng J, Dike S et al.: RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316(5830), 1484-1488 (2007).
214. Zuo T, Tycko B, Liu T-M, Lin H-JL, Huang TH-M: Methods in DNA methylation profling. Epigenomics 1(2), 331-345 (2009).
215. Horard B, Eymery A, Fourel G et al.: Global ana lysis of DNA methylation and transcription of human repetitive sequences. Epigenetics 4(5), 339-350 (2009).
216. Schulz WA: L1 retrotransposons in human cancers. J. Biomed. Biotech. 2006(1), 83672 (2006).
217. Batzer MA, Deininger PL: Alu repeats and human genomic diversity. Nat. Rev. Genet. 3(5), 370-379 (2002).
218. Pace JK, Feschotte C: The evolutionary history of human DNA transposons: evidence for intense activity in the primate lineage. Genome Res. 17(4), 422-432 (2007).
219. Gilbert N, Labuda D: CORE-SINEs: eukaryotic short interspersed retroposing elements with common sequence motifs. Proc. Natl Acad. Sci. USA 96(6), 2869-2874 (1999).
220. Smit AF, Riggs AD: MIRs are classic, tRNA-derived SINEs that amplifed before the mammalian radiation. Nucleic Acids Res. 23(1), 98-102 (1995).
221. Strichman-Almashanu LZ, Lee RS, Onyango PO et al.: A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res. 12(4), 543-554 (2002).
222. Ostertag EM, Goodier JL, Zhang Y, Kazazian HH Jr: SVA elements are nonautonomous retrotransposons that cause disease in humans. Am. J. Hum. Genet. 73(6), 1444-1451 (2003).
223. Wang H, Xing J, Grover D et al.: SVA elements: a hominid-specifc retroposon family. J. Mol. Biol. 354(4), 994-1007 (2005).
224. Warburton PE, Hasson D, Guillem F, Lescale C, Jin XP, Abrusan G: Analysis of the largest tandemly repeated DNA families in the human genome. BMC Genomics 9, 533 (2008).
225. Thoraval D, Asakawa J, Wimmer K et al.: Demethylation of repetitive DNA sequences in neuroblastoma. Genes Chromosomes Cancer 17(4), 234-244 (1996).
226. Ihaka R, Gentleman R: R: A language for data ana lysis and graphics. J. Comput. Graph. Stat. 5, 299-314 (1996).
227. Cleveland WS: Robust locally weighted regression and smoothing scatterplots. J. Am. Stat. Assoc. 74, 829-836 (1979).
228. Qu G, Dubeau L, Narayan A, Yu MC, Ehrlich M: Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutat. Res. 423(1-2), 91-101 (1999).
229. Narayan A, Ji WZ, Zhang XY et al.: Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int. J. Cancer 77(6), 833-838 (1998).
230. Jackson K, Yu MC, Arakawa K et al.: DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol. Ther. 3(12), 1225-1231 (2004).
231. Fanelli M, Caprodossi S, Ricci-Vitiani L et al.: Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. Oncogene 27(3), 358-365 (2008).
232. Park SY, Kim N, Yoo EJ, Cho NY, Kang GH: DNA methylation changes in multistep gastric carcinogenesis and their relationship with H-pylori infection and association of gastric cancer. Lab. Investig. 89, 648 (2009).
233. Tsumagari K, Qi L, Jackson K et al.: Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers. Nucleic Acids Res. 36(7), 2196-2207 (2008).
234. Katargin A, Pavlova L, Kisseljov F, Kisseljova N: Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer. BMC Med. Genomics 2(1), 30 (2009).
235. Nagai H, Kim YS, Yasuda T et al.: A novel sperm-specifc hypomethylation sequence is a demethylation hotspot in human hepatocellular carcinomas. Gene 237(1), 15-20 (1999).
236. Itano O, Ueda M, Kikuchi K et al.: Correlation of postoperative recurrence in hepatocellular carcinoma with demethylation of repetitive sequences. Oncogene 21(5), 789-797 (2002).
237. Nishiyama R, Qi LX, Lacey M, Ehrlich M: Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer. Mol. Cancer Res. 3(11), 617-626 (2005).
238. Nishiyama R, Qi LX, Tsumagari K et al.: A DNA repeat, NBL-2, is hypermethylated in some cancers but hypomethylated in others. Cancer Biol. Ther. 4(4), 440-448 (2005).
239. Cho NY, Kim BH, Yoo EJ et al.: Hypermethylation of CpG island loci and hypomethylation of LINE-I and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J. Pathol. 211(3), 269-277 (2007).
240. Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA: DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br. J. Cancer 80(9), 1312-1321 (1999).
241. Menendez L, Benigno BB, McDonald JF: L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol. Cancer 3, 12 (2004).
242. Takai D, Yagi Y, Habib N, Sugimura T, Ushijima T: Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis. Jpn. J. Clin. Oncol. 30(7), 306-309 (2000).
243. Hervouet E, Debien E, Campion L et al.: Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeats element and genes governing apoptosis and proliferation. Clin. Cancer Res. 15(10), 3519-3529 (2009).
244. Watts G, Futscher B, Holtan N, DeGeest K, Domann F, Rose S: DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage. BMC Med. Genomics 1(1), 47 (2008).
245. Brothman AR, Swanson G, Maxwell TM et al.: Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome? Cancer Genet. Cytogenet. 156(1), 31-36 (2005).
246. Nakagawa T, Kanai Y, Ushijima S, Kitamura T, Kakizoe T, Hirohashi S: DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. J. Urol. 173(5), 1767-1771 (2005).
247. Tangkijvanich P, Hourpai N, Rattanatanyong P, Wisedopas N, Mahachai V, Mutirangura A: Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma. Clin. Chim. Acta 379(1-2), 127-133 (2007). (Pubitemid 46389509)
248. Qu GZ, Grundy PE, Narayan A, Ehrlich M: Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet. Cytogenet. 109(1), 34-39 (1999).
249. Ehrlich M, Hopkins NE, Jiang G et al.: Satellite DNA hypomethylation in karyotyped Wilms tumors. Cancer Genet. Cytogenet. 141(2), 97-105 (2003).
250. Wiemels JL, Hofmann J, Kang M et al.: Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally. Cancer Res. 68(23), 9935-9944 (2008).